BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28375105)

  • 1. The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice.
    Li S; Wang K; Xu G; Ji J; Qin C
    Pak J Pharm Sci; 2016 Nov; 29(6):1907-1912. PubMed ID: 28375105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
    Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
    Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The nitroxide radical TEMPOL prevents obesity, hyperlipidaemia, elevation of inflammatory cytokines, and modulates atherosclerotic plaque composition in apoE-/- mice.
    Kim CH; Mitchell JB; Bursill CA; Sowers AL; Thetford A; Cook JA; van Reyk DM; Davies MJ
    Atherosclerosis; 2015 May; 240(1):234-41. PubMed ID: 25818249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ultrasound Biomicroscopic Imaging for Interleukin-1 Receptor Antagonist-Inhibiting Atherosclerosis and Markers of Inflammation in Atherosclerotic Development in Apolipoprotein-E Knockout Mice.
    Li RJ; Sun Y; Wang Q; Yang J; Yang Y; Song L; Wang Z; Luo XH; Su RJ
    Tex Heart Inst J; 2015 Aug; 42(4):319-26. PubMed ID: 26413013
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Downregulations of CD36 and Calpain-1, Inflammation, and Atherosclerosis by Simvastatin in Apolipoprotein E Knockout Mice.
    Yin M; Liu Q; Yu L; Yang Y; Lu M; Wang H; Luo D; Rong X; Tang F; Guo J
    J Vasc Res; 2017; 54(3):123-130. PubMed ID: 28448973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dihydromyricetin ameliorates atherosclerosis in LDL receptor deficient mice.
    Liu TT; Zeng Y; Tang K; Chen X; Zhang W; Xu XL
    Atherosclerosis; 2017 Jul; 262():39-50. PubMed ID: 28500865
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of tocopheryl phosphates (TPM) on the development of atherosclerosis in apolipoprotein-E deficient mice.
    Libinaki R; Vinh A; Tesanovic-Klajic S; Widdop R; Gaspari T
    Clin Exp Pharmacol Physiol; 2017 Dec; 44 Suppl 1():107-116. PubMed ID: 28744946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of diet-induced atherosclerosis and endothelial dysfunction in apolipoprotein E/angiotensin II type 1A receptor double-knockout mice.
    Wassmann S; Czech T; van Eickels M; Fleming I; Böhm M; Nickenig G
    Circulation; 2004 Nov; 110(19):3062-7. PubMed ID: 15277329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Teneligliptin, a dipeptidyl peptidase-4 inhibitor, attenuated pro-inflammatory phenotype of perivascular adipose tissue and inhibited atherogenesis in normoglycemic apolipoprotein-E-deficient mice.
    Salim HM; Fukuda D; Higashikuni Y; Tanaka K; Hirata Y; Yagi S; Soeki T; Shimabukuro M; Sata M
    Vascul Pharmacol; 2017 Sep; 96-98():19-25. PubMed ID: 28347868
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hydrogen decreases athero-susceptibility in apolipoprotein B-containing lipoproteins and aorta of apolipoprotein E knockout mice.
    Song G; Tian H; Qin S; Sun X; Yao S; Zong C; Luo Y; Liu J; Yu Y; Sang H; Wang X
    Atherosclerosis; 2012 Mar; 221(1):55-65. PubMed ID: 22209213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Crocus sativus L. aqueous extract reduces atherogenesis, increases atherosclerotic plaque stability and improves glucose control in diabetic atherosclerotic animals.
    Christodoulou E; Kadoglou NPE; Stasinopoulou M; Konstandi OA; Kenoutis C; Kakazanis ZI; Rizakou A; Kostomitsopoulos N; Valsami G
    Atherosclerosis; 2018 Jan; 268():207-214. PubMed ID: 29128090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NaoXinTong Inhibits the Advanced Atherosclerosis and Enhances the Plaque Stability in Apolipoprotein E Deficient Mice.
    Yang X; Sun L; Li Y; Ma C; Yang J; Zhang W; Zhao B; Jia L; Duan Y; Han J; Li X; Chen Y
    J Cardiovasc Pharmacol; 2016 Mar; 67(3):203-11. PubMed ID: 26485209
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-inflammatory drug evaluation in ApoE-/- mice by ultrasmall superparamagnetic iron oxide-enhanced magnetic resonance imaging.
    Sigovan M; Kaye E; Lancelot E; Corot C; Provost N; Majd Z; Breisse M; Canet-Soulas E
    Invest Radiol; 2012 Sep; 47(9):546-52. PubMed ID: 22864378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasmalogen modulation attenuates atherosclerosis in ApoE- and ApoE/GPx1-deficient mice.
    Rasmiena AA; Barlow CK; Stefanovic N; Huynh K; Tan R; Sharma A; Tull D; de Haan JB; Meikle PJ
    Atherosclerosis; 2015 Dec; 243(2):598-608. PubMed ID: 26545014
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Specific dietary polyphenols attenuate atherosclerosis in apolipoprotein E-knockout mice by alleviating inflammation and endothelial dysfunction.
    Loke WM; Proudfoot JM; Hodgson JM; McKinley AJ; Hime N; Magat M; Stocker R; Croft KD
    Arterioscler Thromb Vasc Biol; 2010 Apr; 30(4):749-57. PubMed ID: 20093625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renin inhibition by aliskiren prevents atherosclerosis progression: comparison with irbesartan, atenolol, and amlodipine.
    Nussberger J; Aubert JF; Bouzourene K; Pellegrin M; Hayoz D; Mazzolai L
    Hypertension; 2008 May; 51(5):1306-11. PubMed ID: 18391092
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exenatide mitigated diet-induced vascular aging and atherosclerotic plaque growth in ApoE-deficient mice under chronic stress.
    Yang G; Lei Y; Inoue A; Piao L; Hu L; Jiang H; Sasaki T; Wu H; Xu W; Yu C; Zhao G; Ogasawara S; Okumura K; Kuzuya M; Cheng XW
    Atherosclerosis; 2017 Sep; 264():1-10. PubMed ID: 28734203
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clopidogrel significantly lowers the development of atherosclerosis in ApoE-deficient mice in vivo.
    Heim C; Gebhardt J; Ramsperger-Gleixner M; Jacobi J; Weyand M; Ensminger SM
    Heart Vessels; 2016 May; 31(5):783-94. PubMed ID: 26062773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
    Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Red Wine Grape Pomace Attenuates Atherosclerosis and Myocardial Damage and Increases Survival in Association with Improved Plasma Antioxidant Activity in a Murine Model of Lethal Ischemic Heart Disease.
    Rivera K; Salas-Pérez F; Echeverría G; Urquiaga I; Dicenta S; Pérez D; de la Cerda P; González L; Andia ME; Uribe S; Tejos C; Martínez G; Busso D; Irarrázaval P; Rigotti A
    Nutrients; 2019 Sep; 11(9):. PubMed ID: 31500172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.